These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33889269)

  • 1. Influence of hepatitis B virus co-infection on virological and immunological response to antiretroviral treatment among HIV patients attending comprehensive care clinics in Makueni County, Kenya.
    Maitha GM; Kikuvi G; Wanzala P; Kirui F
    Pan Afr Med J; 2021; 38():103. PubMed ID: 33889269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sero-prevalence of Hepatitis B and C viral co-infections among HIV-1 infected ART-naïve individuals in Kumasi, Ghana.
    Boateng R; Mutocheluh M; Dompreh A; Obiri-Yeboah D; Odame Anto E; Owusu M; Narkwa PW
    PLoS One; 2019; 14(4):e0215377. PubMed ID: 31002687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of hepatitis B virus infection on HIV response to antiretroviral therapy in a Chinese antiretroviral therapy center.
    Yang R; Gui X; Xiong Y; Gao SC; Yan Y
    Int J Infect Dis; 2014 Nov; 28():29-34. PubMed ID: 25236390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria.
    Idoko J; Meloni S; Muazu M; Nimzing L; Badung B; Hawkins C; Sankalé JL; Ekong E; Murphy R; Kanki P; Thio CL
    Clin Infect Dis; 2009 Oct; 49(8):1268-73. PubMed ID: 19772386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among human immunodeficiency virus (HIV)-infected patients in an HBV endemic area in Brazil.
    da Silva CM; de Peder LD; Guelere AM; Horvath JD; Silva ES; Teixeira JJV; Bertolini DA
    PLoS One; 2018; 13(9):e0203272. PubMed ID: 30192795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon.
    Mbougua JB; Laurent C; Kouanfack C; Bourgeois A; Ciaffi L; Calmy A; Gwet H; Koulla-Shiro S; Ducos J; Mpoudi-Ngolé E; Molinari N; Delaporte E
    BMC Public Health; 2010 Mar; 10():105. PubMed ID: 20193053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological and virological responses to cART in HIV/HBV co-infected patients from a multicenter cohort.
    Wang H; Li Y; Zhang C; Han Y; Zhang X; Zhu T; Li T
    AIDS; 2012 Sep; 26(14):1755-63. PubMed ID: 22614885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Antiretroviral Therapy on Liver Fibrosis Among Human Immunodeficiency Virus-Infected Adults With and Without HBV Coinfection in Zambia.
    Vinikoor MJ; Sinkala E; Chilengi R; Mulenga LB; Chi BH; Zyambo Z; Hoffmann CJ; Saag MS; Davies MA; Egger M; Wandeler G;
    Clin Infect Dis; 2017 May; 64(10):1343-1349. PubMed ID: 28158504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and impact of hepatitis B and C virus co-infections in antiretroviral treatment naïve patients with HIV infection at a major treatment center in Ghana.
    Sagoe KW; Agyei AA; Ziga F; Lartey M; Adiku TK; Seshi M; Arens MQ; Mingle JA
    J Med Virol; 2012 Jan; 84(1):6-10. PubMed ID: 22095533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohort.
    Ladep NG; Agaba PA; Agbaji O; Muazu A; Ugoagwu P; Imade G; Cooke G; McCormack S; Taylor-Robinson SD; Idoko J; Kanki P
    World J Gastroenterol; 2013 Mar; 19(10):1602-10. PubMed ID: 23538773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+ T Cell Recovery and Hepatitis B Virus Coinfection in HIV-Infected Patients from Côte d'Ivoire Initiating Antiretroviral Therapy.
    Houghtaling L; Moh R; Abdou Chekaraou M; Gabillard D; Anglaret X; Eholié SP; Zoulim F; Danel C; Lacombe K; Boyd A
    AIDS Res Hum Retroviruses; 2018 May; 34(5):439-445. PubMed ID: 29466862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating factors associated to HBV/HIV co-infected patients in antiretroviral treatment clinic, in Northeast Ethiopia.
    Wasihun Y; Asnake D; Kebede N
    BMC Infect Dis; 2024 May; 24(1):460. PubMed ID: 38693473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival.
    Chen M; Wong WW; Law MG; Kiertiburanakul S; Yunihastuti E; Merati TP; Lim PL; Chaiwarith R; Phanuphak P; Lee MP; Kumarasamy N; Saphonn V; Ditangco R; Sim BL; Nguyen KV; Pujari S; Kamarulzaman A; Zhang F; Pham TT; Choi JY; Oka S; Kantipong P; Mustafa M; Ratanasuwan W; Durier N; Chen YM
    PLoS One; 2016; 11(3):e0150512. PubMed ID: 26933963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demographic and clinical factors associated with immune reconstitution in HIV/HBV co-infected and HIV mono-infected patients: a retrospective cohort study.
    Jiang TY; Hou JH; Su B; Zhang T; Yang Y; Liu ZY; Wang W; Guo CP; Dai LL; Sun LJ; Wu H
    HIV Med; 2020 Dec; 21(11):722-728. PubMed ID: 33369028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological and virological response to haart in HIV-1 patients co-infected with hepatitis B and C viruses.
    Okwuraiwe AP; Audu RA; Salu OB; Onwuamah CK; Amoo OS; Ige FA; Meshack EH; Jamda PD; Odunukwe NN; Onwujekwe DI; Ezechi OC; Idigbe EO
    West Afr J Med; 2012; 31(2):124-8. PubMed ID: 23208483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients.
    Otegbayo JA; Taiwo BO; Akingbola TS; Odaibo GN; Adedapo KS; Penugonda S; Adewole IF; Olaleye DO; Murphy R; Kanki P
    Ann Hepatol; 2008; 7(2):152-6. PubMed ID: 18626434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hepatitis B co-infection and response to antiretroviral therapy among HIV-infected patients in Tanzania.
    Hawkins C; Christian B; Ye J; Nagu T; Aris E; Chalamilla G; Spiegelman D; Mugusi F; Mehta S; Fawzi W
    AIDS; 2013 Mar; 27(6):919-927. PubMed ID: 23196935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
    Su S; Fairley CK; Sasadeusz J; He J; Wei X; Zeng H; Jing J; Mao L; Chen X; Zhang L
    J Med Virol; 2018 Mar; 90(3):518-525. PubMed ID: 29091279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective cohort study of immunologic and virologic outcomes in patients with HIV/AIDS and hepatitis virus co-infection in Jos, Nigeria.
    lsa SE; Gwamzhi LN; Akolo C; Giyan J
    Niger J Med; 2010; 19(3):279-85. PubMed ID: 20845631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term treatment outcomes in human immunodeficiency virus type-1 and hepatitis B virus co-infections.
    Sagoe KW; Duedu KO; Ziga F; Agyei AA; Adiku TK; Lartey M; Mingle JA; Arens M
    Ann Clin Microbiol Antimicrob; 2016 Jun; 15(1):38. PubMed ID: 27251610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.